22-50530951-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001014440.4(ODF3B):āc.526G>Cā(p.Glu176Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,611,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001014440.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODF3B | NM_001014440.4 | c.526G>C | p.Glu176Gln | missense_variant | 5/7 | ENST00000329363.9 | NP_001014440.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIMAP1B | ENST00000329363.9 | c.526G>C | p.Glu176Gln | missense_variant | 5/7 | 5 | NM_001014440.4 | ENSP00000382804 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000847 AC: 2AN: 236050Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 129950
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458802Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725638
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.526G>C (p.E176Q) alteration is located in exon 5 (coding exon 4) of the ODF3B gene. This alteration results from a G to C substitution at nucleotide position 526, causing the glutamic acid (E) at amino acid position 176 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at